Home
JW Pharmaceutical

JW Pharmaceutical Market Share Analysis for March 2026

Health > Biotechnology and Pharmaceuticals

Domainjw-pharma.co.kr

Year Founded1945

Employees1001 - 5000

Annual Revenue$200M - $500M

JW Pharmaceutical

JW Pharmaceutical (including company regionals)

jw-pharma.co.kr

See more website traffic and engagement information

JW Pharmaceutical Revenue up to March 2026 is 200M - 500M

revenue generated by JW Pharmaceutical top domains

JW Pharmaceutical top domains revenue over 3 years

Revenue for JW Pharmaceutical top domains

jw-pharma.co.kr200M - 500M

See more with Sales Intelligence

Total visits to JW Pharmaceutical's top domains

Understand JW Pharmaceutical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

jw-pharma.co.kr93.2K

See more with Sales Intelligence

Avg. visit duration in JW Pharmaceutical's top domains

Analyze JW Pharmaceutical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

jw-pharma.co.kr00:02:08

See more with Sales Intelligence

Avg. pageviews on JW Pharmaceutical's top domains

See how JW Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

jw-pharma.co.kr3.59

See more with Sales Intelligence

JW Pharmaceutical top competitors by domain

Top similar sites in March 2026, ranked by their affinity

handok.co.krCompany NameHandokEmployees501 - 1000HQKorea, Republic of, SeoulAnnual revenue$200M - $500MTotal visits61.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by JW Pharmaceutical

These are the website technologies, by industry, used by JW Pharmaceutical top domains

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Widget (2)

Naver map

Audio Video Media (1)

YouTube

More Technologies

4

See all

News & Signals from JW Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJw Pharma is developing Bofanglutide Injection.Under the terms of the agreement, JW Pharmaceutical will be granted the exclusive rights to develop and commercialize Bofanglutide Injection in South Korea.

NewsTempus, Inc. partners with Jw Pharma.Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea, to leverage both real-world data (RWD) and biological modeling to support efficient hypothesis generation and rapid validation in early therapeutic research in oncology.